In the News: New licensing deal for palliative constipation drug - ONA
Links shared publicly online about this topic.
- 120total visits
In the News: New licensing deal for palliative constipation drug - ONA
An exclusive worldwide agreement gives Salix Pharmaceuticals licensing rights to Relistor (methylnaltrexone bromide), a treatment for opioid-induced constipation.
View full resource at oncologynurseadvisor.com
Tags: Constipation, Drug, Pharma, News, Hospice and Palliative Care
Most Recently Shared on July 25, 2011 at 7:02 pm By:
In the News: New licensing deal for palliative constipation drug http://bit.ly/o8bTAE - #palliative
Advertisement
